Hemoglobin
Hemoglobin and Myoglobin
Overview of Hemoglobin and Myoglobin
Both hemoglobin and myoglobin are proteins responsible for oxygen binding.
Hemoglobin is primarily found in blood, while myoglobin is located in skeletal and cardiac muscles.
Hemoglobin
Function: Oxygen transporter in the blood.
Structure:
Globular protein, roughly spherical in shape.
Tetramer composed of four polypeptide chains:
Two identical alpha chains (α1 & α2)
Two identical beta chains (β1 & β2)
Chain Length:
α-chain: 141 amino acids
β-chain: 146 amino acids
Each polypeptide consists of eight alpha-helix sections labeled from A-H, with connecting regions named accordingly (e.g., A-B, B-C).
Specific amino acids in the helical sections are numbered (e.g., Histidine at F-8).
Prosthetic Group:
Contains a heme group, a non-protein component that binds oxygen.
The heme group is composed of a porphyrin ring with a central Fe2+ atom, which binds with oxygen.
Iron in heme is coordinated with four nitrogen atoms from pyrroles in the plane; the fifth position is occupied by the imidazole side chain of His-F-8, and oxygen binds as the sixth ligand.
Myoglobin
Function: Oxygen storer in skeletal and cardiac muscles.
Structure:
Globular protein composed of a single polypeptide chain.
Contains 153 amino acids and consists primarily of eight alpha helices.
Releases oxygen during extreme oxygen deprivation situations, such as exercise.
Heme Group and Oxygen Binding
When oxygen binds to heme, the iron atom shifts position to 0.02 nm above the porphyrin ring, changing the conformation of hemoglobin, which enhances its ability to bind to oxygen.
Cooperativity:
Binding of oxygen to one subunit of hemoglobin increases the affinity of the other subunits for oxygen, known as positive cooperativity.
Biological Function and Conformational Changes
The conformational alteration that occurs during oxygen binding is crucial for hemoglobin's biological function.
Hemoglobin Structures:
Two types of contacts exist in hemoglobin:
Packing Contacts: Shift during conformational changes.
Sliding Contacts: Change during structural transitions.
Hemoglobin exhibits two conformations:
T-state (Tense/Taut):
Deoxyhemoglobin state; oxygen is only accessible to the alpha-chain heme, restricted by steric hindrance.
R-state (Relaxed):
Oxyhemoglobin state where all heme groups are oxygenated, without steric hindrance.
Oxygen Transport Dynamics
Oxygen is delivered to cells through a combination of diffusion and binding with hemoglobin.
Chemical Forms of Oxygen Transport in Blood:
A small fraction of oxygen is dissolved in blood (0.31 mL per 100 mL blood).
The majority is transported as oxyhemoglobin in red blood cells (RBC).
At arterial pH (7.44), oxygen binding shifts in response to H+ ions to facilitate oxygen release in tissues (venous pH = 7.35).
Equations:
For oxyhemoglobin release:
For red blood cell oxygen dissociation:
Oxygen Binding Kinetics
Oxygen binding to hemoglobin is sigmoidal due to allosteric interactions, enhancing the affinity for additional oxygen as each subunit binds.
Myoglobin, in contrast, exhibits a hyperbolic binding curve as it does not participate in cooperativity.
The P50 value indicates the partial pressure of oxygen at which hemoglobin is 50% saturated, with lung partial pressure typically around 100 mm Hg (100% saturation) and peripheral tissues around 40 mm Hg (approximately 75% saturation).
Clinical Aspects of Oxygen Saturation
Hypoxemia: Defined as below-normal levels of oxygen in the arteries, can be caused by conditions such as anemia, ARDS, asthma, congenital heart defects, COPD, etc.
Oxygen Delivery Capacity:
At a pulmonary partial pressure of 100 torr, hemoglobin can exhibit high cooperativity in loading oxygen. If cooperativity were absent, only 79% may remain bound under similar conditions.
This difference exemplifies the efficiency of hemoglobin in oxygen transport, achieved through positive cooperativity.
Bohr Effect and Oxygen Regulation
Active tissues produce CO2 and H+, altering the pH and favoring O2 release due to the Bohr effect.
Hemoglobin can buffer H+ ions, impacting oxygen binding affinity and enhancing release in metabolically active tissues.
Mutations and Genetic Disorders
Sickle-cell Anemia: This genetic disorder results from a mutation where valine replaces glutamate in the β chain of hemoglobin (referred to as hemoglobin S or HbS). Symptoms include chronic pain and increased risk of infections, with treatment options including medications and blood transfusions.
Statistics: Affects approximately 100,000 Americans, particularly prevalent among African Americans (1 in 365 births) and Hispanic Americans (1 in 16,300 births).
Diagnosis of Anemia
Common symptoms include fatigue, irritability, headaches, difficulty concentrating.
Diagnosis may involve a complete blood count (CBC) and oxygen saturation measurement using a pulse oximeter, which should ideally fall between 95% and 100%. Values below 90% are considered a clinical emergency.
Sample Questions for Assessment
What is the oxidation state of iron in hemoglobin and methemoglobin?
Fetal hemoglobin is a tetramer containing what types of protein confirmation?
A. α2, γ2, and β2
B. α2 and β2
C. α2 and γ2
D. γ2 and β2
True or False: Myoglobin is a tetramer.
True or False: Oxygen loading to hemoglobin is partial pressure dependent.
What mutation causes sickle-cell anemia?
E. Valine replaces glutamate at position 6 on the surface of the beta chain.
F. Glutamate replaces valine at position 6 on the surface of the beta chain.